Lilly shares slide on second big patent setback - FiercePharma

Links shared publicly online about this topic.

  • 951
    total visits

Lilly shares slide on second big patent setback - FiercePharma

fiercepharma.com —

Eli Lilly (NYSE: LLY) has been hit with yet another key loss on the generic drug front, losing its case in federal court to protect its patent for the ADHD drug Strattera. And this one could prove... Read more...

View full resource at fiercepharma.com

Tags: ADHD, Drug, Strattera, Eli Lilly and Company

  • Share

Most Recently Shared on August 14, 2010 at 1:51 am By:

sstrumello Scott Strumello

FiercePharma: "Lilly shares slide on second big patent setback" http://bit.ly/bNrmYx

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

Peter H Brown Peter H Brown

Advertisement